NYXOAH 1.240 € (-0,48 %) MONTEA 68.300 € (0,00 %) XIOR 28.200 € (+0,89 %) UMICORE 20.720 € (+2,88 %) ONTEX GROUP 2.250 € (-6,05 %) HYLORIS 4.600 € (-2,13 %) KBC 121.550 € (+0,54 %) TINC 11.520 € (+0,70 %) AB INBEV 72.580 € (-1,79 %) BEKAERT 39.900 € (-4,89 %) LOTUS BAKERIES 11 400.000 € (+0,88 %) ARGENX SE 759.600 € (-2,06 %) UCB 229.400 € (-8,57 %) SYENSQO 77.550 € (+8,54 %) DEME GROUP 167.200 € (+1,83 %) SOLVAY 26.920 € (+0,67 %) SOFINA 244.000 € (+0,74 %) TUBIZE-FIN 197.800 € (-7,57 %) ASCENCIO 52.400 € (+0,58 %) EVS 27.350 € (-0,91 %) EKOPAK 3.640 € (-1,49 %) GBL 79.200 € (+1,15 %) VGP 86.200 € (+0,23 %) JENSEN-GROUP 82.800 € (-0,24 %) WDP 22.620 € (+0,09 %) D'IETEREN GROUP 183.800 € (+1,21 %) VAN DE VELDE 29.800 € (-0,67 %) AGEAS 71.400 € (+0,71 %) BELYSSE GROUP 0.495 € (-2,94 %) BIOTALYS 2.400 € (+0,84 %) COLRUYT 39.340 € (+1,34 %) MELEXIS 68.050 € (+1,57 %) KINEPOLIS GROUP 41.000 € (-1,09 %) FAGRON 23.350 € (-0,21 %) ORANGE BELGIUM 22.100 € (-0,45 %) ELIA GROUP 126.700 € (-1,09 %) AEDIFICA 71.250 € (-0,21 %) CELYAD ONCOLOGY 0.270 € (-1,10 %) AZELIS GROUP 11.840 € (+3,95 %) CMB.TECH 13.740 € (+0,73 %) KBC ANCORA 86.600 € (+0,58 %) ACKERMANS V.HAAREN 268.600 € (+1,97 %) ONWARD MEDICAL 2.370 € (0,00 %) SHURGARD 25.900 € (+1,17 %) VIOHALCO 17.020 € (-0,23 %) RECTICEL 12.120 € (-0,16 %) BREDERODE 102.800 € (+0,39 %) NYRSTAR 0.060 € (0,00 %) PROXIMUS 6.370 € (+0,08 %) BPOST 1.532 € (+0,26 %) GIMV 44.500 € (+0,23 %) IBA 16.080 € (+0,88 %) HOME INVEST BE. 20.450 € (+2,00 %) CFE 11.900 € (-0,83 %) BARCO 8.005 € (+1,20 %) AGFA-GEVAERT 0.386 € (+0,13 %) TITAN S.A. 52.050 € (+0,77 %) SOLVAC NOM(RETAIL) 79.500 € (+5,30 %) VASTNED 29.400 € (+0,86 %) CARE PROPERTY INV. 12.800 € (+0,31 %)
AYVENS 12.130 € (+4,84 %)
LOUIS HACHETTE 1.793 € (+1,07 %)
FDJ UNITED 22.420 € (-2,52 %)
CVC CAPITAL 14.890 € (+3,33 %)
EMEIS 14.370 € (+3,23 %)
EXOSENS 57.500 € (-0,86 %)
OPMOBILITY 13.050 € (+2,35 %)
VIRIDIEN 78.750 € (-1,13 %)
SOITEC 96.920 € (+0,75 %)
J.MARTINS,SGPS 18.390 € (+5,15 %)
TECHNIP ENERGIES 27.960 € (-14,29 %)
PHARMING GROUP 0.842 € (-23,35 %)
WOLTERS KLUWER 73.220 € (-1,19 %)
BOUYGUES 49.370 € (+6,95 %)
MAGNUM 16.260 € (+0,77 %)
SCHNEIDER ELECTRIC 272.700 € (+6,19 %)
CAPGEMINI 105.400 € (-1,59 %)
ADP 124.400 € (+10,87 %)
THE NAVIGATOR COMP 3.276 € (+1,17 %)
UMG 19.875 € (+0,35 %)
ASML HOLDING 1 378.200 € (+1,17 %)
ADYEN 884.100 € (+0,35 %)
ELIS 24.840 € (-4,68 %)
SANOFI 77.100 € (-3,53 %)
SAINT GOBAIN 76.700 € (+1,51 %)
BAM GROEP KON 11.010 € (+3,28 %)
TOTALENERGIES 75.550 € (-0,37 %)
DSM FIRMENICH AG 93.980 € (+12,71 %)
RENAULT 27.920 € (+0,04 %)
DANONE 69.920 € (-0,94 %)
Vusion 138.500 € (+2,14 %)
CIECHARGEURSINVEST 8.590 € (-0,23 %)
LVMH 473.800 € (+1,25 %)
AIR LIQUIDE 171.620 € (+0,08 %)
2CRSI 24.300 € (+1,84 %)
PHILIPS KON 23.330 € (+2,32 %)
ATOS GROUP 31.140 € (-7,38 %)
STMICROELECTRONICS 43.435 € (+1,26 %)
BE SEMICONDUCTOR 189.000 € (-0,26 %)
ASM INTERNATIONAL 742.800 € (+3,17 %)
VALLOUREC 20.570 € (-2,97 %)
QUADIENT 13.540 € (+0,59 %)
ING GROEP N.V. 29.335 € (+2,03 %)
HERMES INTL 1 547.500 € (+2,59 %)
B.COM.PORTUGUES 1.041 € (+2,36 %)
SOCIETE GENERALE 78.440 € (+2,24 %)
FUGRO 9.528 € (+1,74 %)
ENGIE 26.320 € (+1,35 %)
APERAM 44.240 € (-4,20 %)
ESSILORLUXOTTICA 167.850 € (+1,67 %)
BNP PARIBAS ACT.A 107.060 € (+0,13 %)
STELLANTIS NV 5.019 € (-4,96 %)
L'OREAL 398.250 € (+3,85 %)
ACCOR 46.720 € (-1,21 %)
EDP 4.465 € (-0,84 %)
PERNOD RICARD 69.260 € (+1,44 %)
NEXANS 127.100 € (-1,17 %)
VINCI 124.100 € (+4,90 %)
VEOLIA ENVIRON. 35.650 € (+1,42 %)
BENETEAU 6.090 € (+2,87 %) News Réglementées
|
30/07/2026 09:00
Original-Research: INDUS Holding AG (von NuWays AG): BUYOriginal-Research: INDUS Holding AG - from NuWays AG Classification of NuWays AG to INDUS Holding AG
Material momentum triggers sig. guidance hike; PT Up Yesterday, INDUS significantly hiked its guidance in expectation of an exceptional Q2 result, given strong momentum in Material Solutions related to the tungsten special situation. In detail: Prel. Q2 revenue rose by 20.6% yoy to € 523.7m, notably beating our expectation of € 486m. The key contributor was Material Solutions, with portfolio company BETEK performing exceptionally strongly amidst the current supply shortage in tungsten products. It benefitted from pricing, additional high-margin orders across all application areas, and gained market share. We attribute € 50-60m (eNuW) of revenue to this special situation as a positive one-off effect. At the same time, the other two segments were indicated to have performed in line with expectations. Prel. Q2 adj. EBITA skyrocketed by 160.5% yoy to € 81m (eNuW: € 37.6m) as the adj. EBITA margin expanded by 8.2pp yoy to 15.3%, mainly benefitting from the substantially higher margins on current orders in Material Solutions. In our view, this reflects a positive one-off of € 40-45m (eNuW). FY26 guidance significantly raised. INDUS now expects to reach € 1.9-2.1bn in revenue, € 220-260m in adj. EBITA and an 11-13% adj. EBITA margin, instead of € 1.85-2.05bn in sales and € 160-190m in adj. EBITA at an adj. EBITA margin of 8-10%. In our view, the increase (especially on the margin side) should mainly result from the positive one-off effect related to tungsten and hence does not reflect a sustainable margin level going forward. Special situation to boost FY26 EPS. We project EPS to double compared to FY25 to € 5.5/share, as Chinese export restrictions and high tungsten demand, partially driven by global defense, seem unlikely to normalize in the short term (at least in H2) at this point. We hence assume that BETEK's current commercial momentum will largely persist in FY26. In our opinion, this windfall potentially provides room for accelerated inorganic growth or additional shareholder returns. Confirming BUY at a raised PT of € 41 (previously € 37), as we move from FCFY26 to FCFY27 to better reflect a more normalized operational picture of the group. You can download the research here: indus-holding-ag-2026-07-30-update-en-6a605 For additional information visit our website: https://www.nuways-ag.com/research Contact for questions: NuWays AG - Equity Research Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse. ++++++++++ The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 2373996 30.07.2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||
© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière